NCT04605029

Brief Summary

This pilot study will study the impact of critical illness and ICU processes of care on the trajectory and development of frailty. It is hypothesize that frailty in survivors of critical illness will be measurable at hospital discharge, will correlate with processes of care while in ICU and will better discriminate long term outcomes when compared to severity of illness or the degree of frailty present on ICU admission. This pilot study will be conducted in a tertiary medical surgical ICU at Kingston General Hospital- Kingston, Ontario. It will inform the feasibility, timelines and sample size for the multi-center study and will allow for the refinement of study procedures and data collection methods. This study will be published separately as a stand-alone pilot.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2017

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
10 months until next milestone

First Posted

Study publicly available on registry

October 27, 2020

Completed
Last Updated

October 27, 2020

Status Verified

October 1, 2020

Enrollment Period

2.4 years

First QC Date

October 30, 2018

Last Update Submit

October 21, 2020

Conditions

Keywords

Frailty

Outcome Measures

Primary Outcomes (4)

  • Number of patients with a measure of frailty prior to hospital discharge.

    Measure of the Frailty Index and Clinical Frailty Scale prior to discharge

    6 months

  • Correlation of frailty severity at hospital discharge with long term outcomes (mortality, Quality of Life and Need for Institutionalization)

    Clinical outcomes at 6 months will include mortality, Quality of Life (EQ5L) and need for Institutionalization

    6 months

  • Impact of admission critical illness on the development and severity of frailty as measured by a Frailty Index or Clinical Frailty Scale

    Correlation with the progression or presence of frailty as measured with the Frailty Index or Clinical Frailty Scale

    28 days and at 6 months

  • Correlation of ICU processes of care (nutritional adequacy, mobilization and sedation) with frailty progression as measured by the Clinical Frailty Scale or Frailty Index

    Correlation of processes of care in ICU (nutritional adequacy, mobilization and sedation) with frailty progression

    28 days

Study Arms (1)

Critically Ill patients

No Intervention

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals who are admitted to an intensive care unit requiring therapeutic life support.

You may qualify if:

  • Age \> 55 years
  • Admission to ICU for over 24 hours
  • Receipt of at least one therapeutic life support intervention that can only be delivered in the ICU such as mechanical ventilation (both invasive and non-invasive), vasoactive medications (vasopressors or inotropes) or acute renal replacement therapy.

You may not qualify if:

  • Expected to survive for less than 72 hours after ICU admission.
  • Inability to obtain baseline blood work less than 48 hours after ICU admission (i.e. study enrollment must occur within 48 hours of ICU admission allowing for the blood work to be done in the time allowed).
  • No family or caregivers available to collect collateral history.
  • Not able to speak English with lack of available medical translators.
  • Admission to ICU with acute structural neurological disease:
  • Massive stroke requiring ICU care
  • Spinal cord injury with neurological deficit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kingston Health Sciences Centre

Kingston, Ontario, K7L 2V7, Canada

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Cytokine levels and measures of immunocompetence

MeSH Terms

Conditions

Critical IllnessFrailty

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Critical Care Research Director

Study Record Dates

First Submitted

October 30, 2018

First Posted

October 27, 2020

Study Start

August 1, 2017

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

October 27, 2020

Record last verified: 2020-10

Locations